Correlation Between Inhibrx and Oruka Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Oruka Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Oruka Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Oruka Therapeutics,, you can compare the effects of market volatilities on Inhibrx and Oruka Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Oruka Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Oruka Therapeutics,.
Diversification Opportunities for Inhibrx and Oruka Therapeutics,
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Inhibrx and Oruka is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Oruka Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oruka Therapeutics, and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Oruka Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oruka Therapeutics, has no effect on the direction of Inhibrx i.e., Inhibrx and Oruka Therapeutics, go up and down completely randomly.
Pair Corralation between Inhibrx and Oruka Therapeutics,
Given the investment horizon of 90 days Inhibrx is expected to under-perform the Oruka Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Inhibrx is 1.16 times less risky than Oruka Therapeutics,. The stock trades about 0.0 of its potential returns per unit of risk. The Oruka Therapeutics, is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 1,452 in Oruka Therapeutics, on September 2, 2024 and sell it today you would earn a total of 721.00 from holding Oruka Therapeutics, or generate 49.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Oruka Therapeutics,
Performance |
| Timeline |
| Inhibrx |
| Oruka Therapeutics, |
Inhibrx and Oruka Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Oruka Therapeutics,
The main advantage of trading using opposite Inhibrx and Oruka Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Oruka Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oruka Therapeutics, will offset losses from the drop in Oruka Therapeutics,'s long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| Oruka Therapeutics, vs. Tff Pharmaceuticals | Oruka Therapeutics, vs. Eliem Therapeutics | Oruka Therapeutics, vs. Inhibrx | Oruka Therapeutics, vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |